Literature DB >> 9525538

Rate of caffeine metabolism and risk of spontaneous abortion.

L Fenster1, C Quale, R A Hiatt, M Wilson, G C Windham, N L Benowitz.   

Abstract

In a case-control study of 73 women with and 141 women without spontaneous abortion, the authors determined the activity of the three principal caffeine-metabolizing enzymes--cytochrome P-4501A2 (CYP1A2), xanthine oxidase, and N-acetyltransferase 2--by measuring levels of caffeine metabolites in urine. After examining the effect of enzyme activity and different levels of caffeine intake, they concluded that there was no evidence that an interaction between enzyme activity and caffeine intake during pregnancy resulted in risk of spontaneous abortion. In a subsample comparing 24 cases with recurrent (two or more) spontaneous abortions and 21 controls with two or more livebirths and no previous spontaneous abortions, the unadjusted odds ratio for low CYP1A2 enzyme activity (below the median) was 0.92 (95% confidence interval (CI) 0.28-3.04) compared with higher CYP1A2 activity. The odds ratio for risk of recurrent spontaneous abortion and low xanthine oxidase activity (below the median) versus higher activity was 0.37 (95% CI 0.10-1.29). Phenotypically slow acetylators (N-acetyltransferase 2 index <0.37) had an odds ratio of 1.58 (95% CI 0.48-5.13) for recurrent loss compared with rapid acetylators. Thus, some association of the latter two caffeine-metabolizing enzymes with recurrent spontaneous abortion is suggested but may also be due to chance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525538     DOI: 10.1093/oxfordjournals.aje.a009477

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  5 in total

1.  PharmGKB summary: caffeine pathway.

Authors:  Caroline F Thorn; Eleni Aklillu; Ellen M McDonagh; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-05       Impact factor: 2.089

Review 2.  Evaluation of the reproductive and developmental risks of caffeine.

Authors:  Robert L Brent; Mildred S Christian; Robert M Diener
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2011-03-02

Review 3.  Caffeine: cognitive and physical performance enhancer or psychoactive drug?

Authors:  Simone Cappelletti; Daria Piacentino; Piacentino Daria; Gabriele Sani; Mariarosaria Aromatario
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

4.  The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance.

Authors:  Dominik H Pesta; Siddhartha S Angadi; Martin Burtscher; Christian K Roberts
Journal:  Nutr Metab (Lond)       Date:  2013-12-13       Impact factor: 4.169

Review 5.  Energy Drinks and Sports Performance, Cardiovascular Risk, and Genetic Associations; Future Prospects.

Authors:  Jorge Gutiérrez-Hellín; David Varillas-Delgado
Journal:  Nutrients       Date:  2021-02-24       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.